• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares (NQ:KNSA)

    47.30 +0.22 (+0.47%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 350,988
    Open 47.35
    Bid (Size) 46.00 (200)
    Ask (Size) 48.25 (100)
    Prev. Close 47.08
    Today's Range 46.60 - 48.45
    52wk Range 19.41 - 50.03
    Shares Outstanding 71,726,685
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Fits the Minervini Trend Template with High-Growth Momentum ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Presents a Compelling Growth and Technical Setup ↗
    Via Chartmill

    Performance

    YTD
    +12.6%
    +12.6%
    1 Month
    +3.3%
    +3.3%
    3 Month
    +15.0%
    +15.0%
    6 Month
    +27.7%
    +27.7%
    1 Year
    +128.6%
    +128.6%

    More News

    Read More
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Presents a High-Growth Momentum Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top GARP Investment ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Shows Strong Growth and Bullish Chart Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Shows High-Growth Momentum and Strong Technical Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA): A Prime Example of Affordable Growth (GARP) Investing ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Compelling Value Investment ↗
    Via Chartmill
    News headline image
    Kiniksa (KNSA) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines Strong Growth with Bullish Technical Setup ↗
    Via Chartmill
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Combines High Growth Momentum with Strong Technical Setup ↗
    Via Chartmill
    News headline image
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Fits the High-Growth Momentum and Trend Template Strategy ↗
    Via Chartmill
    News headline image
    Kiniksa (KNSA) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Combines Technical Strength and Fundamental Growth Momentum ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For October 28, 2025 ↗
    Via Benzinga
    News headline image
    What to Expect from Kiniksa Pharmaceuticals's Earnings ↗
    Via Benzinga
    News headline image
    5 Analysts Have This To Say About Kiniksa Pharmaceuticals ↗
    Via Benzinga
    News headline image
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Identified by High Growth Momentum and Minervini Trend Screen ↗
    Via Chartmill
    News headline image
    What Analysts Are Saying About Kiniksa Pharmaceuticals Stock ↗
    Via Benzinga
    News headline image
    Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Shows High-Growth Momentum and Strong Technical Setup ↗
    Via Chartmill
    News headline image
    Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Emerges as an Affordable Growth Opportunity ↗
    Via Chartmill
    News headline image
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Emerges as a Top Affordable Growth Candidate ↗
    Via Chartmill
    News headline image
    Kiniksa Pharmaceuticals (NASDAQ:KNSA) Exhibits High Growth Momentum and Technical Breakout Potential ↗
    Via Chartmill
    News headline image
    KINIKSA PHARMACEUTICALS INTE (NASDAQ:KNSA): A Strong Growth Stock with a Positive Technical Breakout ↗
    Via Chartmill
    News headline image
    Kiniksa Pharmaceuticals International (NASDAQ:KNSA) – An Affordable Growth Stock with Strong Fundamentals and Fair Valuation ↗
    Via Chartmill

    Frequently Asked Questions

    Is Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares publicly traded?
    Yes, Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is publicly traded.
    What exchange does Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trade on?
    Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
    The ticker symbol for Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is KNSA on the Nasdaq Stock Market
    What is the current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
    The current price of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 47.30
    When was Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares last traded?
    The last trade of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares was at 04/13/26 04:00 PM ET
    What is the market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares?
    The market capitalization of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares is 3.39B
    How many shares of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares are outstanding?
    Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares has 3B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.